Denali Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-330
| Closed | -$1K | – | 289 |
|
|
2018
Q4 | $1K | Hold |
330
| – | – | ﹤0.01% | 248 |
|
|
2018
Q3 | $1K | Hold |
330
| – | – | ﹤0.01% | 250 |
|
|
2018
Q2 | $1K | Hold |
330
| – | – | ﹤0.01% | 272 |
|
|
2018
Q1 | $1K | Hold |
330
| – | – | ﹤0.01% | 263 |
|
|
2017
Q4 | $1K | Hold |
330
| – | – | ﹤0.01% | 266 |
|
|
2017
Q3 | $1K | Hold |
330
| – | – | ﹤0.01% | 261 |
|
|
2017
Q2 | $1K | Hold |
330
| – | – | ﹤0.01% | 261 |
|
|
2017
Q1 | $1K | Hold |
330
| – | – | ﹤0.01% | 267 |
|
|
2016
Q4 | $1K | Hold |
330
| – | – | ﹤0.01% | 276 |
|
|
2016
Q3 | $1K | Hold |
330
| – | – | ﹤0.01% | 280 |
|
|
2016
Q2 | $1K | Hold |
330
| – | – | ﹤0.01% | 279 |
|
|
2016
Q1 | $1K | Hold |
330
| – | – | ﹤0.01% | 281 |
|
|
2015
Q4 | $1K | Hold |
330
| – | – | ﹤0.01% | 277 |
|
|
2015
Q3 | $2K | Hold |
330
| – | – | ﹤0.01% | 254 |
|
|
2015
Q2 | $2K | Sell |
330
-449,600
| -100% | -$2.72M | ﹤0.01% | 263 |
|
|
2015
Q1 | $3.17M | Sell |
449,930
-347,900
| -44% | -$2.45M | 0.73% | 54 |
|
|
2014
Q4 | $6.15M | Sell |
797,830
-35,200
| -4% | -$271K | 1.74% | 17 |
|
|
2014
Q3 | $6.22M | Buy |
833,030
+567,300
| +213% | +$4.24M | 1.79% | 15 |
|
|
2014
Q2 | $2.57M | Buy |
+265,730
| New | +$2.57M | 0.7% | 56 |
|